Cargando…
Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
The emergence of immunotherapy has revolutionized the treatment landscape for various types of cancer. Nevertheless, lung cancer remains one of the leading causes of cancer-related mortality worldwide due to the development of resistance in most patients. As one of the most abundant groups of immune...
Autores principales: | Liu, Lei, Chen, Genwang, Gong, Sisi, Huang, Rongfu, Fan, Chunmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679371/ https://www.ncbi.nlm.nih.gov/pubmed/38022518 http://dx.doi.org/10.3389/fimmu.2023.1274547 |
Ejemplares similares
-
PHLDA1 modulates microglial response and NLRP3 inflammasome signaling following experimental subarachnoid hemorrhage
por: Lai, Jinqing, et al.
Publicado: (2023) -
Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy
por: Tao, Hongxia, et al.
Publicado: (2023) -
Origin, activation, and targeted therapy of glioma-associated macrophages
por: Xu, Can, et al.
Publicado: (2022) -
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023) -
Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment
por: Sang, Xiaoqing, et al.
Publicado: (2021)